Table 2 Clinical characteristics at baseline.

From: Effluent and serum protein N-glycosylation is associated with inflammation and peritoneal membrane transport characteristics in peritoneal dialysis patients

Clinical parameter

Number of patients

Median ± interquartile range

M

F

M

F

Diabetes

10

22

  

CAPD/APD

53/10

27/4

  

Dianeal/Physioneal

55/8

23/8

  

Time on PD (months)

62

31

16.80 ± 20.50

12.20 ± 21.50

DPCrea4

63

31

0.74 ± 0.14

0.70 ± 0.15

Ultrafiltration_PET (mL)

63

31

400.00 ± 344.30

540.00 ± 398.20

IL-6 (ρg/mL)

61

30

96.74 ± 138.87

71.16 ± 119.13

IL-8 (ρg/mL)

60

30

35.44 ± 93.00

19.81 ± 49.25

MCP-1 (ρg/mL)

61

30

247.01 ± 178.99

171.91 ± 118.38

TGFβ-1 (ρg/mL)

61

30

75.05 ± 82.78

93.43 ± 77.05

VEGF (ρg/mL)

60

29

146.94 ± 114.11

102.58 ± 140.27

CA-125 (ρg/mL)

61

30

19.60 ± 18.40

21.45 ± 13.6

HA (ρg/mL)

61

30

179.11 ± 138.27

148.52 ± 129.13

  1. Given are the numbers of patients (M, male/F, female) with available data on the stated parameter. See Table 1 for total patient number at study month 0. The following clinical parameters were used as confounders for regression analysis with GEE, next to age and sex: Diabetes; CAPD, Continuous Ambulatory Peritoneal Dialysis; APD, Automated Peritoneal Dialysis; Dianeal or Physioneal treatment group; time on PD (refers to the total time in months after a patient was first introduced to PD treatment). The Dianeal group was randomised into two treatment groups at baseline, i.e. 27/11 male/female patients continued with Dianeal for 24 months, while 28/12 male/female patients switched to Physioneal for the following 24 months. DPCrea4 is the ratio of creatinine in the effluent vs. plasma during 4-h dwell time.
Back to article page